607 related articles for article (PubMed ID: 18616513)
61. Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1.
Møller MN; Werther K; Nalla A; Stangerup SE; Thomsen J; Bøg-Hansen TC; Nielsen HJ; Cayé-Thomasen P
Laryngoscope; 2010 Apr; 120(4):657-62. PubMed ID: 20205165
[TBL] [Abstract][Full Text] [Related]
62. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
63. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
[TBL] [Abstract][Full Text] [Related]
64. Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma.
Xu K; Hou S; Du Z
Chin Med J (Engl); 2002 May; 115(5):743-5. PubMed ID: 12133547
[TBL] [Abstract][Full Text] [Related]
65. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
66. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
[TBL] [Abstract][Full Text] [Related]
67. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.
Wahlin BE; Sander B; Christensson B; Kimby E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):388-97. PubMed ID: 17255259
[TBL] [Abstract][Full Text] [Related]
68. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
69. Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2004 Jan; 72(1):1-9. PubMed ID: 14962256
[TBL] [Abstract][Full Text] [Related]
70. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Liu WW; Zeng ZY; Wu QL; Hou JH; Chen YY
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):395-400. PubMed ID: 15746850
[TBL] [Abstract][Full Text] [Related]
71. Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression.
Saito B; Shiozawa E; Yamochi-Onizuka T; Adachi D; Nakamaki T; Tomoyasu S; Omine M; Mitsuya T; Takimoto M; Ota H
Pathol Int; 2004 Sep; 54(9):667-74. PubMed ID: 15363034
[TBL] [Abstract][Full Text] [Related]
72. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer.
Mino N; Takenaka K; Sonobe M; Miyahara R; Yanagihara K; Otake Y; Wada H; Tanaka F
J Surg Oncol; 2007 Mar; 95(3):250-7. PubMed ID: 17323339
[TBL] [Abstract][Full Text] [Related]
73. Gelatinases and their tissue inhibitors during human ovulation: increased expression of tissue inhibitor of matrix metalloproteinase-1.
Lind AK; Dahm-Kähler P; Weijdegård B; Sundfeldt And K; Brännström M
Mol Hum Reprod; 2006 Dec; 12(12):725-36. PubMed ID: 17071711
[TBL] [Abstract][Full Text] [Related]
74. Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.
Aljada IS; Ramnath N; Donohue K; Harvey S; Brooks JJ; Wiseman SM; Khoury T; Loewen G; Slocum HK; Anderson TM; Bepler G; Tan D
J Clin Oncol; 2004 Aug; 22(16):3218-29. PubMed ID: 15249585
[TBL] [Abstract][Full Text] [Related]
75. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
[TBL] [Abstract][Full Text] [Related]
76. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Väisänen AH; Kallioinen M; Turpeenniemi-Hujanen T
Hum Pathol; 2008 Mar; 39(3):377-85. PubMed ID: 18187184
[TBL] [Abstract][Full Text] [Related]
77. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
78. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
[TBL] [Abstract][Full Text] [Related]
79. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Curran S; Dundas SR; Buxton J; Leeman MF; Ramsay R; Murray GI
Clin Cancer Res; 2004 Dec; 10(24):8229-34. PubMed ID: 15623598
[TBL] [Abstract][Full Text] [Related]
80. Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer.
Nakopoulou L; Katsarou S; Giannopoulou I; Alexandrou P; Tsirmpa I; Panayotopoulou E; Mavrommatis J; Keramopoulos A
Mod Pathol; 2002 Jan; 15(1):26-34. PubMed ID: 11796838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]